Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Substance Abuse Treatment, Prevention, and Policy|April 10, 2021
Mandatory treatment for methamphetamine use in AustraliaMathew Coleman, Kelly Ridley, Michael Christmass
International Journal of Mental Health Nursing|August 5, 2024
Diagnostic Overshadowing of Chronic Hepatitis C in People With Mental Health Conditions Who Inject Drugs: A Scoping ReviewRegan Preston, Michael Christmass, Eric Lim, et al.
Drug and Alcohol Review|July 8, 2021
A clinical research priority setting study for issues related to the use of methamphetamine and emerging drugs of concern in AustraliaKrista J Siefried, Nadine Ezard, Michael Christmass, et al.
European Addiction Research|March 18, 2024
Measuring Objective and Subjective Sleep during Lisdexamfetamine Treatment of Acute Methamphetamine Withdrawal: A Feasibility StudyLiam S Acheson, Christopher Gordon, Rebecca McKetin, et al.
Drug and Alcohol Dependence|November 18, 2022
Lisdexamfetamine for the treatment of acute methamphetamine withdrawal: A pilot feasibility and safety trialLiam S Acheson, Nadine Ezard, Nicholas Lintzeris, et al.
Plos One|October 3, 2022
Trial protocol of an open label pilot study of lisdexamfetamine for the treatment of acute methamphetamine withdrawalLiam S Acheson, Nadine Ezard, Nicholas Lintzeris, et al.
The International Journal on Drug Policy|March 13, 2024
Participant experiences in a pilot study for methamphetamine withdrawal treatment: Implications for retentionLiam S Acheson, Simon Clay, Rebecca McKetin, et al.
The International Journal on Drug Policy|October 14, 2022
Awareness of hepatitis C virus infection status among people who inject drugs in a setting of universal direct-acting antiviral therapy: The ETHOS Engage studyHeather Valerio, Anna Conway, Maryam Alavi, et al.
Drug and Alcohol Review|May 30, 2023
Perspectives and sentiments on contingency management from people who use methamphetamineSimon Clay, Zachary Wilkinson, Meredith Ginley, et al.
Pageof 3